Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990104906> ?p ?o ?g. }
- W2990104906 endingPage "11217" @default.
- W2990104906 startingPage "11194" @default.
- W2990104906 abstract "The P2X4 receptor is a ligand-gated ion channel that is expressed on a variety of cell types, especially those involved in inflammatory and immune processes. High-throughput screening led to a new class of P2X4 inhibitors with substantial CYP 3A4 induction in human hepatocytes. A structure-guided optimization with respect to decreased pregnane X receptor (PXR) binding was started. It was found that the introduction of larger and more polar substituents on the ether linker led to less PXR binding while maintaining the P2X4 inhibitory potency. This translated into significantly reduced CYP 3A4 induction for compounds 71 and 73. Unfortunately, the in vivo pharmacokinetic (PK) profiles of these compounds were insufficient for the desired profile in humans. However, BAY-1797 (10) was identified and characterized as a potent and selective P2X4 antagonist. This compound is suitable for in vivo studies in rodents, and the anti-inflammatory and anti-nociceptive effects of BAY-1797 were demonstrated in a mouse complete Freund’s adjuvant (CFA) inflammatory pain model." @default.
- W2990104906 created "2019-12-05" @default.
- W2990104906 creator A5020632057 @default.
- W2990104906 creator A5036690578 @default.
- W2990104906 creator A5038269097 @default.
- W2990104906 creator A5040786897 @default.
- W2990104906 creator A5043793127 @default.
- W2990104906 creator A5044797966 @default.
- W2990104906 creator A5049085425 @default.
- W2990104906 creator A5051781291 @default.
- W2990104906 creator A5052905984 @default.
- W2990104906 creator A5054997015 @default.
- W2990104906 creator A5062949066 @default.
- W2990104906 creator A5065894881 @default.
- W2990104906 creator A5084284786 @default.
- W2990104906 creator A5084893201 @default.
- W2990104906 creator A5084998409 @default.
- W2990104906 date "2019-11-20" @default.
- W2990104906 modified "2023-09-27" @default.
- W2990104906 title "Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile" @default.
- W2990104906 cites W1506664007 @default.
- W2990104906 cites W1516646538 @default.
- W2990104906 cites W1906452216 @default.
- W2990104906 cites W1964678173 @default.
- W2990104906 cites W1975907544 @default.
- W2990104906 cites W1979801278 @default.
- W2990104906 cites W1982672989 @default.
- W2990104906 cites W1986221995 @default.
- W2990104906 cites W2000720249 @default.
- W2990104906 cites W2007223406 @default.
- W2990104906 cites W2018934217 @default.
- W2990104906 cites W2027236524 @default.
- W2990104906 cites W2036835440 @default.
- W2990104906 cites W2054643756 @default.
- W2990104906 cites W2074072981 @default.
- W2990104906 cites W2078336096 @default.
- W2990104906 cites W2078435077 @default.
- W2990104906 cites W2083392615 @default.
- W2990104906 cites W2088876815 @default.
- W2990104906 cites W2090527768 @default.
- W2990104906 cites W2098976226 @default.
- W2990104906 cites W2114367386 @default.
- W2990104906 cites W2119792097 @default.
- W2990104906 cites W2124026197 @default.
- W2990104906 cites W2133425774 @default.
- W2990104906 cites W2145280844 @default.
- W2990104906 cites W2172417680 @default.
- W2990104906 cites W2193158796 @default.
- W2990104906 cites W2210120548 @default.
- W2990104906 cites W2216699036 @default.
- W2990104906 cites W2225272104 @default.
- W2990104906 cites W2277444342 @default.
- W2990104906 cites W2331812936 @default.
- W2990104906 cites W2513150856 @default.
- W2990104906 cites W2549373848 @default.
- W2990104906 cites W2614066293 @default.
- W2990104906 cites W2731965142 @default.
- W2990104906 cites W2767901905 @default.
- W2990104906 cites W2808107271 @default.
- W2990104906 cites W3928460 @default.
- W2990104906 cites W4247076899 @default.
- W2990104906 cites W4248872320 @default.
- W2990104906 cites W2027320187 @default.
- W2990104906 doi "https://doi.org/10.1021/acs.jmedchem.9b01304" @default.
- W2990104906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31746599" @default.
- W2990104906 hasPublicationYear "2019" @default.
- W2990104906 type Work @default.
- W2990104906 sameAs 2990104906 @default.
- W2990104906 citedByCount "28" @default.
- W2990104906 countsByYear W29901049062020 @default.
- W2990104906 countsByYear W29901049062021 @default.
- W2990104906 countsByYear W29901049062022 @default.
- W2990104906 countsByYear W29901049062023 @default.
- W2990104906 crossrefType "journal-article" @default.
- W2990104906 hasAuthorship W2990104906A5020632057 @default.
- W2990104906 hasAuthorship W2990104906A5036690578 @default.
- W2990104906 hasAuthorship W2990104906A5038269097 @default.
- W2990104906 hasAuthorship W2990104906A5040786897 @default.
- W2990104906 hasAuthorship W2990104906A5043793127 @default.
- W2990104906 hasAuthorship W2990104906A5044797966 @default.
- W2990104906 hasAuthorship W2990104906A5049085425 @default.
- W2990104906 hasAuthorship W2990104906A5051781291 @default.
- W2990104906 hasAuthorship W2990104906A5052905984 @default.
- W2990104906 hasAuthorship W2990104906A5054997015 @default.
- W2990104906 hasAuthorship W2990104906A5062949066 @default.
- W2990104906 hasAuthorship W2990104906A5065894881 @default.
- W2990104906 hasAuthorship W2990104906A5084284786 @default.
- W2990104906 hasAuthorship W2990104906A5084893201 @default.
- W2990104906 hasAuthorship W2990104906A5084998409 @default.
- W2990104906 hasConcept C104317684 @default.
- W2990104906 hasConcept C109650736 @default.
- W2990104906 hasConcept C111919701 @default.
- W2990104906 hasConcept C112705442 @default.
- W2990104906 hasConcept C132040763 @default.
- W2990104906 hasConcept C150903083 @default.
- W2990104906 hasConcept C170493617 @default.
- W2990104906 hasConcept C181199279 @default.
- W2990104906 hasConcept C185592680 @default.